p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells

Oncogene

Volumn 22, Issue 15, 2003, Pages 2322-2333

  Thompson, H Garrett R ^a   Harris, Joseph W ^a   Wold, Barbara J ^b   Lin, Fritz ^c   Brody, James P ^a  

^a University of California at Irvine   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; P62; PDEF; Promoter; Proteasome inhibitor; SQSTM1

Indexed keywords

MASPIN; MESSENGER RNA; PROTEASOME INHIBITOR; PROTEIN P62; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; BREAST TUMOR; CANCER CELL; CONTROLLED STUDY; EPITHELIUM CELL; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ACETYLCYSTEINE; BREAST; BREAST NEOPLASMS; CARRIER PROTEINS; CELLS, CULTURED; COMPUTER SYSTEMS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUPEPTINS; MULTIENZYME COMPLEXES; NEOPLASM PROTEINS; OLIGOPEPTIDES; PROMOTER REGIONS (GENETICS); PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; UBIQUITIN;

EID: 0037994340     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206325     Document Type: Article

References (44)

1. Adams J. (2001). Semin. Oncol., 28, 613-619.
2. Afrikanova I, Yeh E, Bartos D, Watowich SS and Longmore GD. (2002). Oncogene, 21, 1272-1284.
3. An B, Goldfarb RH, Siman R and Dou QP. (1998). Cell Death Differ., 5, 1062-1075.
4. Benz CC, O'Hagan RC, Richter B, Scott GK, Chang CH, Xiong X, Chew K, Ljung BM, Edgerton S, Thor A and Hassell JA. (1997). Oncogene, 15, 1513-1525.
5. Bojovic BB and Hassell JA. (2001). J. Biol. Chem., 276, 4509-4521.
6. Bradford MM. (1976). Anal. Biochem., 72, 248-254.
7. Chen H, Nandi AK, Li X and Bieberich CJ. (2002). Cancer Res., 62, 338-340.
8. de Launoit Y, Chotteau-Lelievre A, Beaudoin C, Coutte L, Netzer S, Brenner C, Huvent I and Baert JL. (2000). Adv. Exp. Med. Biol., 480, 107-116.
9. DeSalle LM and Pagano M. (2001). FEBS Lett, 490, 179-189.
10. Dittmer J and Nordheim A. (1998). Biochim. Biophys. Acta., 1377, F1-F11.
11. Fan XM, Wong BC, Wang WP, Zhou XM, Cho CH, Yuen ST, Leung SY, Lin MC, Kung HF and Lam SK. (2001). Int. J. Cancer, 93, 481-488.
12. Geetha T and Wooten MW. (2002). FEBS Lett., 512, 19-24.
13. Ghadersohi A and Sood AK. (2001). Clin. Cancer Res., 7, 2731-2738.
14. Gong J, Xu J, Bezanilla M, van Huizen R, Derin R and Li M. (1999). Science, 285, 1565-1569.
15. Greenall A, Willingham N, Cheung E, Boam DS and Sharrocks AD. (2001). J. Biol. Chem., 276, 16207-16215.
16. Higashino F, Yoshida K, Noumi T, Seiki M and Fujinaga K. (1995). Oncogene, 10, 1461-1463.
17. Hiroumi H, Dosaka-Akita H, Yoshida K, Shindoh M, Ohbuchi T, Fujinaga K and Nishimura M. (2001). Int. J. Cancer, 93, 786-791.
18. Hochstrasser M. (1996). Annu. Rev. Genet, 30, 405-439.
19. Joung I, Strominger JL and Shin J. (1996). Proc. Natl. Acad. Sci. USA, 93, 5991-5995.
20. Keyomarsi K and Pardee AB. (1993). Proc. Natl. Acad. Sci. USA, 90, 1112-1116.
21. Kornitzer D and Ciechanover A. (2000). J. Cell Physiol., 182, 1-11.
22. Kuusisto E, Suuronen T and Salminen A. (2001). Biochem. Biophys. Res. Commun., 280, 223-228.
23. Lee YH, Ko J, Joung I, Kim JH and Shin J. (1998). FEBS Lett., 438, 297-300.
24. Nagamura-Inoue T, Tamura T and Ozato K. (2001). Int. Rev. Immunol., 20, 83-105.
25. Nozawa M, Yomogida K, Kanno N, Nonomura N, Miki T, Okuyama A, Nishimune Y and Nozaki M. (2000). Cancer Res., 60, 1348-1352.
26. Oettgen P, Finger E, Sun Z, Akbarali Y, Thamrongsak U, Boltax J, Grall F, Dube A, Weiss A, Brown L, Quinn G, Kas K, Endress G, Kunsch C and Libermann TA. (2000). J. Biol. Chem., 275, 1216-1225.
27. Owa T, Yoshino H, Yoshimatsu K and Nagasu T. (2001). Curr. Med. Chem., 8, 1487-1503.
28. Pasquini LA, Besio Moreno M, Adamo AM, Pasquini JM and Soto EF. (2000). J. Neurosci. Res., 59, 601-611.
29. Rachubinski RA, Marcus SL and Capone JP. (1999). J. Biol. Chem., 274, 18278-18284.
30. Sanz L, Diaz-Meco MT, Nakano H and Moscat J. (2000). EMBO J., 19, 1576-1586.
31. Sanz L, Sanchez P, Lallena MJ, Diaz-Meco MT and Moscat J. (1999). EMBO J., 18, 3044-3053.
32. Sharrocks AD. (2001). Nat. Rev Mol. Cell Biol., 2, 827-837.
33. Shin J. (1998). Arch. Pharm. Res., 21, 629-633.
34. Spataro V, Norbury C and Harris AL. (1998). Br. J. Cancer, 77, 448-455.
35. Su Z, Shi Y and Fisher PB. (2000). Oncogene, 19, 3411-3421.
36. Sudo T, Maruyama M and Osada H. (2000). Biochem. Biophys. Res. Commun., 269, 521-525.
37. Trimble MS, Xin JH, Guy CT, Muller WJ and Hassell JA. (1993). Oncogene, 8, 3037-3042.
38. Vadlamudi RK, Joung I, Strominger JL and Shin J. (1996). J. Biol. Chem., 271, 20235-20237.
39. Vadlamudi RK and Shin J. (1998). FEBS Lett., 435, 138-142.
40. Wasylyk B, Hagman J and Gutierrez-Hartmann A. (1998). Trends Biochem. Sci., 23, 213-216.
41. Watson DK, McWilliams-Smith MJ, Nunn MF, Duesberg PH, O'Brien SJ and Papas TS. (1985). Proc. Natl. Acad. Sci. USA, 82, 7294-7298.
42. Xing X, Wang SC, Xia W, Zou Y, Shao R, Kwong KY, Yu Z, Zhang S, Miller S, Huang L and Hung MC. (2000). Nat. Med., 6, 189-195.
43. Yamada N, Tamai Y, Miyamoto H and Nozaki M. (2000). Gene, 241, 267-274.
44. Yamada T, Abe M, Higashi T, Yamamoto H, Kihara-Negishi F, Sakurai T, Shirai T and Oikawa T. (2001). Blood, 97, 2300-2307.